Physician profile
Sara Batool
NPI 1306290713
$1,655.74
in general payments reported to CMS, 2019-2025
14 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.17 · 2022: $133 · 2023: $452 · 2024: $772 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,485.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $417.85 | 2023-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $404.59 | 2023-2025 | Qelbree, Qelbree |
| Ironshore Pharmaceuticals INC. | $170.84 | 2023-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $156.20 | 2022-2024 | Bexsero, Rotarix, Pediarix |
| Sanofi-Aventis U.S. LLC | $95.94 | 2024-2025 | |
| Vertical Pharmaceuticals, LLC | $91.25 | 2024-2025 | Relexxii |
| Neos Therapeutics, Lp | $77.39 | 2023-2024 | Adzenys Xr-Odt |
| Cognoa, INC. | $70.12 | 2021-2022 | |
| Seqirus USA INC | $50.79 | 2024 | Flucelvax |
| Kaleo, INC. | $40.99 | 2022 | |
| Amgen INC. | $23.87 | 2024 | |
| Lnhc, INC | $19.64 | 2025 | Zelsuvmi |
| Merck Sharp & Dohme LLC | $18.61 | 2022 | |
| Collegium Pharmaceutical, INC. | $17.66 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Batool listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.